Posted in Business, Pipeline How former Acorda CEO Ron Cohen landed at a Parkinson’s cell therapy startup March 24, 2026 BioPharma Dive Cohen says he looked at around two dozen companies since Acorda wound down. PipelineNeuroscience Read full story